Secondary Hormonal Syndromes in Patients with Sporadic Neuroendocrine Tumors

#906

Introduction: Neuroendocrine tumors (NETs) are characterized by secretion of peptide hormones that may cause distinct syndromes. Although most patients with hormonal secretion are diagnosed upon primary diagnosis, a significant proportion of pancreatic NET patients develop secondary hormonal production later on in the disease.

Aim(s): To determine the frequency of symptomatic secondary hormonal production in NETs.

Materials and methods: This was a retrospective analysis of patients (n=972) with NET treated at our institution; Uppsala Academic Hospital, Uppsala, Sweden. We selected sporadic patients with symptoms of secondary hormonal excess (conversion) that were confirmed by biochemistry testing.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Crona J, Eriksson B, Welin S,

Keywords: neuroendocrine tumor, prognostic factors,

To read the full abstract, please log into your ENETS Member account.